American Journal of Respiratory and Critical Care Medicine · 2003 · 762 citations · 19 references
MedicineClinical SciencesInternal MedicinePulmonary Function TestingPulmonologySurvival AnalysisDyspnea AssessmentForced Vital CapacityInterstitial Lung DiseaseLung VolumesPulmonary Function AssessmentPulmonary PathologyAlveolar-arterial Oxygen GradientDyspnea MeasurementDyspnea PrognosticationLung FibrosisLung Function DeclineLung Function TestingOxygen SaturationTotal Lung Capacity
There is significant heterogeneity in survival time among patients with idiopathic pulmonary fibrosis. Studies of baseline clinical and physiologic variables as predictors of survival time have reported inconsistent results. We evaluated the predictive value of changes in clinical and physiologic variables over time for survival time in 81 patients with biopsy-proven idiopathic pulmonary fibrosis. Six-month changes in dyspnea score, total lung capacity, thoracic gas volume, FVC, FEV1, diffusing capacity of carbon monoxide, partial pressure of arterial oxygen, oxygen saturation, and alveolar-arterial oxygen gradient were predictive of survival time even after adjustment for baseline values. Analyses were repeated on 51 patients with 12-month change data. Twelve-month changes in dyspnea score, total lung capacity, FVC, partial pressure of arterial oxygen, oxygen saturation, and alveolar-arterial oxygen gradient were predictive of survival time after adjustment for baseline values. Evaluation of changes in clinical and physiological variables over 6 and 12 months may provide clinicians with more accurate prognostic information than baseline values alone.
19
international consensus statement
Roger V. Clements, Arnold Simanowitz · 2000 · 854 citations
Talmadge E. King, Marvin I. Schwarz, Kevin M. Brown et al. · American Journal of Respiratory and Critical Care Medicine · 2001 · 633 citations